Current Headlines

  1. Boston Scientific Builds Momentum With Cardiac Rhythm Devices, Gains Flexibility
    7/29/2016

    Boston Scientific credits its “category leadership strategy” for the company’s staggering 27 percent net income growth in the second quarter of 2016. CEO Mike Mahoney commented that Boston Scientific is aiming for “as much financial flexibility as we can have” and is on track to sustain momentum in its cardiac rhythm management business (CRM), which had lagged due to a lack of MRI-compatible products.

  2. FDA Finalizes Guidance On Adaptive Clinical Study Designs
    7/29/2016

    Final guidance from the U.S. Food and Drug Administration (FDA) for staff and sponsors lays out how to plan and implement adaptive designs for clinical studies when used in medical device development programs and submissions for Premarket Approval Applications (PMA), premarket notification (510(k)) submissions, de novo submissions (Evaluation of Automatic Class III Designation), Humanitarian Device Exemption (HDE) applications and Investigational Device Exemption (IDE).

  3. Baxter Revenue Boosted By Hospital Products Business, Strategic M&A
    7/28/2016

    Baxter achieved better-than-expected second quarter sales and significant growth in its hospital products business. CEO José Almeida reported that the company is on track with its strategy outlined earlier this year, with continued growth resulting from a “disciplined focus” on portfolio management, innovation, and capital allocation for M&A.

  4. FDA Clarifies Use Of Real-World Evidence In Regulatory Decision-Making
    7/28/2016

    The U.S. Food and Drug Administration (FDA) has issued draft guidance that clarifies how it intends to evaluate real-world evidence (RWE) to support regulatory decisions.

  5. Philips CEO: Full Focus Now On Health Technology
    7/27/2016

    Following the successful listing of its lighting business on the Euronext Amsterdam Stock Exchange in May, Royal Philips can now focus squarely on its HealthTech business, according to its chief executive.

  6. Zimmer Biomet Launches Signature Solutions For Value-Based Healthcare
    7/27/2016

    Zimmer Biomet announced its plans to leverage the company’s years of consulting experience with its cultivated portfolio of technologies and analytical tools to create an “end-to-end” suite of clinical services called Signature Solutions. The intent of the service is to drive greater efficiency and improve patient outcomes in hospitals while working with the hospitals’ existing infrastructure.

  7. Boston Scientific Announces Acquisition Of Cosman Medical
    7/27/2016

    Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired Cosman Medical, Inc., a privately held Burlington, Mass. manufacturer of radiofrequency ablation (RFA) systems.

  8. Bio-Inspired Microrobots Shapeshift, Move With Magnets
    7/26/2016

    Taking inspiration from bacteria, a team of Swiss scientists has developed a platform for developing microrobots that can be customized for various medical indications, such as delivering drugs or performing delicate surgical operations, including unblocking clogged arteries. These tiny robots shapeshift in response to heat and can be remotely controlled using electromagnetic fields.

  9. GE Leaders: Healthcare Executing Well, Feels Sustainable
    7/26/2016

    GE Healthcare posted a strong second quarter, and the conglomerate's top executives believe that favorable markets and real opportunities for growth will keep the unit’s performance sustainable.

  10. Globus Medical Expands Distribution Reach With Acquisition Of Alphatec’s International Business
    7/26/2016

    Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC) for $80.0 million in cash, subject to certain closing adjustments.